(Q40022074)

16 September 2017

Antitumoral activity of rapamycin mediated through inhibition of HIF-1alpha and VEGF in hepatocellular carcinoma (English)

1 reference

16 September 2017

1 reference

Wei Wang

1

1 reference

16 September 2017

Wei-Dong Jia

2

1 reference

16 September 2017

Ge-Liang Xu

3

1 reference

16 September 2017

Zhi-Hua Wang

4

1 reference

16 September 2017

Jian-Sheng Li

5

1 reference

16 September 2017

Jin-Liang Ma

6

1 reference

16 September 2017

Yong-Sheng Ge

7

1 reference

16 September 2017

Sheng-Xue Xie

8

1 reference

16 September 2017

Ji-Hai Yu

9

1 reference

16 September 2017

language of work or name

1 reference

4 December 2008

1 reference

Digestive Diseases and Sciences

16 September 2017

1 reference

16 September 2017

54

1 reference

16 September 2017

10

1 reference

16 September 2017

2128-2136

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-008-0605-3

16 September 2017

0 references

cites work

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-008-0605-3

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

21 January 2018

1 reference

12 December 2020

Synergistic effect of mTOR inhibitor rapamycin and fluorouracil in inducing apoptosis and cell senescence in hepatocarcinoma cells

1 reference

12 December 2020

Environmental factors and risk for hepatocellular carcinoma

1 reference

12 December 2020

Observation of incipient tumor angiogenesis that is independent of hypoxia and hypoxia inducible factor-1 activation

1 reference

12 December 2020

Global cancer statistics, 2002

1 reference

12 December 2020

Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis

1 reference

12 December 2020

mTOR-targeted therapy of cancer with rapamycin derivatives

1 reference

12 December 2020

Hypoxic regulation of vascular endothelial growth factor through the induction of phosphatidylinositol 3-kinase/Rho/ROCK and c-Myc

1 reference

12 December 2020

Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance.

1 reference

12 December 2020

Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer.

1 reference

12 December 2020

Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma

1 reference

12 December 2020

Overexpression of vascular endothelial growth factor and the development of post-transplantation cancer

1 reference

12 December 2020

Defining the role of mTOR in cancer

1 reference

12 December 2020

Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.

1 reference

12 December 2020

PKC zeta mTOR pathway: a new target for rituximab therapy in follicular lymphoma

1 reference

12 December 2020

Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma

1 reference

12 December 2020

PKC-eta mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways

1 reference

12 December 2020

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

1 reference

12 December 2020

Hypoxia inducible factor-1 independent pathways in tumor angiogenesis.

1 reference

12 December 2020

Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma

1 reference

12 December 2020

Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma

1 reference

12 December 2020

Modification of an in vivo lung metastasis model of hepatocellular carcinoma by low dose N-nitrosomorpholine and diethylnitrosamine

1 reference

12 December 2020

Regulation of mTOR and S6K1 activation by the nPKC isoforms, PKCepsilon and PKCdelta, in adult cardiac muscle cells

1 reference

12 December 2020

Antiangiogenesis by cyclosporine

1 reference

12 December 2020

Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma

1 reference

12 December 2020

10.1007/S10620-008-0605-3

Identifiers

DOI

1 reference

16 September 2017

1 reference